Health Care • Medical/Dental Instruments
$52.90 ▲ +0.66
(+1.26%)
MKT CAP: $3.73B • VOL: 250.5K
52W L $13 52W H $59
ROARABLE / RQD
D- • 39/100
PIOTROSKI
2 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$44
MEDIAN
$59
MEAN
$60
HIGH
$72
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE PLSE TAPE
PLSE // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $64.01 | $60.83 | 2025-02-14 | $48.14 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $66.65 | $62.42 | 2025-02-06 | $49.73 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $60.31 | $58.19 | 2025-01-29 | $50.78 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $53.96 | — | 2025-01-17 | $51.84 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $46.55 | $50.25 | 2025-01-09 | $47.08 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $62.95 | $55.02 | 2024-12-18 | $46.02 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $51.31 | $53.43 | 2024-12-04 | $49.20 | -4.3% | 48% | C |